Method for judging feature of malignant tumor

Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Biological or biochemical

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S007230, C530S350000

Reexamination Certificate

active

07634362

ABSTRACT:
A method for judging feature of malignant tumor is described herein. The method comprises obtaining step, first comparing step, second comparing step, and judging step. The obtaining step comprises obtaining a first parameter based on activity and expression level of a first CDK contained in a tumor cell of the malignant tumor, a second parameter based on activity and expression level of a second CDK contained in the tumor cell, a third parameter based on the first parameter and the second parameter, and a fourth parameter based on expression level of a growth factor receptor in the tumor cell. The first comparing step comprises comparing a first threshold value with the third parameter. The second comparing step comprises comparing a second threshold value with the fourth parameter. The judging step comprises judging the feature based on the comparison results of the first comparing step and the second comparing step. Also described is a computer program or program product executing the steps of the method.

REFERENCES:
patent: 2003/0050470 (2003-03-01), An et al.
patent: 2004/0018525 (2004-01-01), Wirtz et al.
patent: 2004/0229294 (2004-11-01), Chan-Hui et al.
patent: 2005/0079518 (2005-04-01), Baker et al.
patent: 2005/0131057 (2005-06-01), Ueno et al.
patent: 2007/0134669 (2007-06-01), Verjat
patent: 2008/0153098 (2008-06-01), Rimm et al.
patent: 1 233 060 (2002-08-01), None
patent: 1 512 755 (2005-03-01), None
patent: 1 600 513 (2005-11-01), None
patent: 2 334 578 (1999-08-01), None
patent: WO 00/47998 (2000-08-01), None
patent: WO 02/096867 (2002-12-01), None
patent: 2004/076686 (2004-09-01), None
Ishihara et al. “A new cancer diagnostic system based on a CDK profiling technology” Biochimica et Biophysica Acta, vol. 1741, No. 3, Jun. 20, 2005, pp. 226-233, XP002402956.
Ross et al, “Molecular Biology/Biochemistry 13 HER-2/NEU Oncogene Amplification and P34CDC2 Cyclin Dependent Kinase Overexpression Predict Recurrence in Protate Cancer”, Proceedings for the Annual Meeting of the American Association for Cancer Research, New York, NY, US, vol. 38, Mar. 1997, p. 277, 1, XP002926940, Abstract.
Heikki Joensuu et al., “Amplification oferbB2 and erbB2 Expression Are Superior to Estrogen Receptor Status As Risk Factors for Distant Recurrence in pT1N0M0 Breast Cancer: A Nationwide.Population-based Study”, Clinical Cancer Research, Mar. 2003, 923-930, vol. 9.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for judging feature of malignant tumor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for judging feature of malignant tumor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for judging feature of malignant tumor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4106031

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.